Telum Therapeutics
Noáin, ES · Founded 2019 · 22 employees on LinkedIn · 4 known investors
Find your way into Telum Therapeutics
Sign up to see every warm intro you have to Telum Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Telum Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Telum Therapeutics develops antimicrobial drugs using synthetic biology and AI-driven machine learning, specializing in engineered lytic proteins to address multidrug-resistant infections. The company serves pharmaceutical and healthcare markets focused on treating infectious diseases with high unmet medical needs.
Founders & leadership
Investors · 4
AMR Action Fundlisted by AMR Action FundBoston
How we know: AMR Action Fund's portfolio page · Not right? Tell us
Invivo Capital Partnerslisted by Invivo Capital PartnersBarcelona · $2.2M – $4.3M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Telum Therapeutics do?
- Telum Therapeutics develops antimicrobial drugs using synthetic biology and AI-driven machine learning, specializing in engineered lytic proteins to address multidrug-resistant infections. The company serves pharmaceutical and healthcare markets focused on treating infectious diseases with high unmet medical needs.
- Who are Telum Therapeutics's investors?
- Telum Therapeutics's investors include AMR Action Fund, Invivo Capital Partners, Clave, Clave Capital.
- Where is Telum Therapeutics headquartered?
- Telum Therapeutics is headquartered in Noáin, ES.



